Minactivin expression in human monocyte and macrophage populations
- PMID: 3926024
Minactivin expression in human monocyte and macrophage populations
Abstract
Adherent monolayer cultures of human blood monocytes, peritoneal macrophages, bone marrow macrophages, and colonic mucosa macrophages were examined for their ability to produce and secrete minactivin, a specific inactivator of urokinase-type plasminogen activator. All except colonic mucosa macrophages produced and secreted appreciable amounts of minactivin, but only blood monocytes were stimulated by muramyl dipeptide (adjuvant peptide) to increase production. The minactivin from each of these populations could be shown to preferentially inhibit urokinase-type plasminogen activator and not trypsin, plasmin, or "tissue"-type plasminogen activator (HPA66). A plasminogen-activating enzyme present in monocyte cultures appeared unaffected by the presence of minactivin and could be shown to be regulated independently by dexamethasone.
Similar articles
-
Minactivin: a human monocyte product which specifically inactivates urokinase-type plasminogen activators.Eur J Biochem. 1983 Nov 15;136(3):517-22. doi: 10.1111/j.1432-1033.1983.tb07771.x. Eur J Biochem. 1983. PMID: 6416839
-
Novel properties of human monocyte plasminogen activator.Eur J Biochem. 1984 Mar 1;139(2):253-8. doi: 10.1111/j.1432-1033.1984.tb08001.x. Eur J Biochem. 1984. PMID: 6199200
-
Proenzyme to urokinase-type plasminogen activator in human colon cancer: in vitro inhibition by monocyte minactivin after proteolytic activation.Eur J Cancer Clin Oncol. 1987 Feb;23(2):213-22. doi: 10.1016/0277-5379(87)90017-4. Eur J Cancer Clin Oncol. 1987. PMID: 2965017
-
Plasminogen activation and regulation of pericellular proteolysis.Biochim Biophys Acta. 1985 Nov 12;823(1):35-65. doi: 10.1016/0304-419x(85)90014-9. Biochim Biophys Acta. 1985. PMID: 2413894 Review. No abstract available.
-
Plasminogen activators and their inhibitors in arthritic disease.Ann N Y Acad Sci. 1992 Dec 4;667:87-100. doi: 10.1111/j.1749-6632.1992.tb51602.x. Ann N Y Acad Sci. 1992. PMID: 1309075 Review. No abstract available.
Cited by
-
Evidence for a CD14+ population of monocytes in inflammatory bowel disease mucosa--implications for pathogenesis.Clin Exp Immunol. 1995 May;100(2):291-7. doi: 10.1111/j.1365-2249.1995.tb03667.x. Clin Exp Immunol. 1995. PMID: 7538056 Free PMC article.
-
Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors.J Cell Biol. 1987 Apr;104(4):801-4. doi: 10.1083/jcb.104.4.801. J Cell Biol. 1987. PMID: 3031083 Free PMC article. Review. No abstract available.
-
Alpha 2-macroglobulin restricts plasminogen activation to the surface of RC2A leukemia cells.Cell Regul. 1991 Dec;2(12):1057-65. doi: 10.1091/mbc.2.12.1057. Cell Regul. 1991. PMID: 1724917 Free PMC article.
-
Interleukin 8: cells of origin in inflammatory bowel disease.Gut. 1996 Jan;38(1):90-8. doi: 10.1136/gut.38.1.90. Gut. 1996. PMID: 8566866 Free PMC article.
-
Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants.J Cell Biol. 1989 May;108(5):1987-95. doi: 10.1083/jcb.108.5.1987. J Cell Biol. 1989. PMID: 2523891 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources